Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study.

@article{Pearlman1997OncedailyCE,
  title={Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study.},
  author={David S. Pearlman and William Raymond Lumry and Juan Pablo Atal Hugo {\~N}opo Natalia Winder and Michael J Noonan},
  journal={Clinical pediatrics},
  year={1997},
  volume={36 4},
  pages={
          209-15
        }
}
Cetirizine (once daily), a highly selective H1-antagonist, is efficacious for treating seasonal allergic rhinitis (SAR), perennial allergic rhinitis, and chronic idiopathic urticaria. A 4-week, randomized, double-blind, placebo-controlled trial investigated the safety and efficacy of cetirizine syrup (5 or 10 mg daily) in 209 children ages 6 to 11 years with SAR. Parents assisted patients in recording symptom severity (sneezing, nasal discharge, itchy eyes, itchy nose or mouth, conjunctivitis… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 citations